 |
|
|
| |
Real-world Outcomes With New HCV Antivirals in HIV/HCV-coinfected Subjects:
Madrid Coinfection Registry (Madrid-CoRE) Findings
|
| |
| |
Reported by Jules Levin
AASLD 2016 Nov 11-15 Boston, MA
angela Gil-Martin1, Juan J. Gonzalez-Garcia2, Encarnacion Cruz-Martos1, Ana Moreno3, Lourdes Dominguez4, Marisa Montes2, Teresa Aldamiz-Echevarria5, Maria J. Tellez6, Ignacio Santos7, Laura Benitez15, Jose Sanz9, Pablo Ryan10, Gabriel Gaspar11, Miguel Gorgolas17, Juan E. Losa12, Rafael Torres-Perea13, Carlos Barros14, Juan V. San Martin16, Sari Arponen18, Maria Jose Calvo1, Marta Alcaraz1, Inmaculada Jarrin8, Juan Berenguer5
1Subdireccion General de Farmacia y Productos Sanitarios, SERMAS, Madrid, Spain. 2Hospital La Paz/IdiPaz, Madrid, Spain. 3Hospital Universitario Ramon y Cajal, Madrid, Spain. 4Hospital Universitario 12 de Octubre/imas12 , Madrid, Spain. 5Hospital General Universitario Gregorio Maraņon/IiSGM, Madrid, Spain. 6Hospital Universitario Clinico San Carlos, Madrid, Spain. 7Hospital de la Princesa, Madrid, Spain. 8Instituto de Salud Carlos III, Madrid, Spain. 9Hospital Principe de Asturias, Alcala de Henares, Spain. 10Hospital Infanta Leonor, Madrid, Spain. 11Hospital de Getafe, Getafe, Spain. 12Fundacion Hospital de Alcorcon, Alcorcon, Spain. 13Hospital Universitario Severo Ochoa, Leganes, Spain. 14Hospital Universitario de Mostoles, Mostoles, Spain. 15Hospital Puerta de Hierro, Majadahonda, Spain. 16Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain. 17Fundacion Jimenez Diaz, Madrid, Spain.18Hospital de Torrejon, Madrid, Spain.
|
| |
|
|
|
|
|
